Halozyme has completed its acquistion of Antares Pharma, creating a leading drug delivery business. View details here.
For InvestorsAntares Pharma: Making Medicines Feel Better

SEC Filings

Search By Keyword:
Filter By Year:
Filter By Type:
Showing 51 to 100 of 618
Date Title Type
2022-04-2910-K/A [Amend] - Annual report [Section 13 and 1510-K/A
2022-04-29SC 13D - General statement of acquisition of beneSC 13D
2022-04-26SC TO-T - Tender offer statement by Third PartySC TO-T
2022-04-26SC 14D9 - Solicitation, recommendation statementsSC 14D9
2022-04-13SC14D9C - Written communication relating to thirdSC14D9C
2022-04-13SC TO-C - Written communication relating to an isSC TO-C
2022-04-13SC TO-C - Written communication relating to an isSC TO-C
2022-04-13SC TO-C - Written communication relating to an isSC TO-C
2022-04-13SC14D9C - Written communication relating to thirdSC14D9C
2022-04-138-K - Current report8-K
2022-03-078-K - Current report8-K
2022-03-038-K - Current report8-K
2022-03-0310-K - Annual report [Section 13 and 15(d), not S10-K
2022-02-14SC 13G - Statement of acquisition of beneficial oSC 13G
2022-02-01SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2022-01-128-K/A [Amend] - Current report8-K/A
2022-01-118-K - Current report8-K
2021-12-168-K - Current report8-K
2021-11-048-K - Current report8-K
2021-11-0410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2021-11-028-K - Current report8-K
2021-10-288-K - Current report8-K
2021-10-188-K - Current report8-K
2021-08-188-K - Current report8-K
2021-08-0510-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2021-08-058-K - Current report8-K
2021-06-24S-8 - Securities to be offered to employees in emS-8
2021-06-158-K - Current report8-K
2021-06-018-K - Current report8-K
2021-05-068-K - Current report8-K
2021-05-0610-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2021-04-27DEFA14A - Additional definitive proxy soliciting DEFA14A
2021-04-27DEF 14A - Other definitive proxy statementsDEF 14A
2021-03-058-K - Current report8-K
2021-03-0210-K - Annual report [Section 13 and 15(d), not S10-K
2021-03-028-K - Current report8-K
2021-01-28SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2021-01-118-K - Current report8-K
2020-11-128-K - Current report8-K
2020-11-0510-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2020-11-058-K - Current report8-K
2020-10-018-K - Current report8-K
2020-09-218-K - Current report8-K
2020-08-068-K - Current report8-K
2020-08-0610-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2020-06-168-K - Current report8-K
2020-05-058-K - Current report8-K
2020-05-0510-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2020-04-27DEF 14A - Other definitive proxy statementsDEF 14A
2020-04-27DEFA14A - Additional definitive proxy soliciting DEFA14A
Showing 51 to 100 of 618